RG6794

News alerts, weekly reports and conference planners

Company:

Regor, Roche

Drug class:

CDK2/4 inhibitor

Related drugs:

‹

›

CCNE1 overexpression	Estrogen Receptor Positive Breast Cancer	CCNE1 overexpression	Estrogen Receptor Positive Breast Cancer	RG6794 Sensitive: D – Preclinical RG6794 Sensitive : D	RG6794 Sensitive: D – Preclinical RG6794 Sensitive : D
ER positive	Estrogen Receptor Positive Breast Cancer	ER positive	Estrogen Receptor Positive Breast Cancer	RG6794 Sensitive: D – Preclinical RG6794 Sensitive : D	RG6794 Sensitive: D – Preclinical RG6794 Sensitive : D

Associations
(2)